Search PubMed⌕ Search

Biomedical subjects

A Chodkowska

Publications and source records attributed to A Chodkowska.

38 records · Page 3Linked to original sources

Effects of pentagastrin and oxyphenonium on the levels of serotonin and 5-hydroxyindoleacetic acid in different parts of the digestive tract, blood and brain of rats.

In the experiments of Wistar rats it was found that pentagastrin in a dose of 0.6 microgram/kg decreased the level of serotonin and increased that of 5-HIAA in the stomach wall, and in a dose of 3 micrograms/kg it had no effect on these parameters, while in a dose of 6 micrograms/kg it decreased only the serotonin level. Oxyphenonium 0.5 mg/kg increased only the 5-HIAA level in the stomach, and in a dose of 5 mg/kg it decreased also the level of serotonin, In the duodenum these substances remained unchanged after pentagastrin administration, but oxyphenonium 5 mg/kg caused a significant fall of serotonin and increase of 5-HIAA, which was associated with a decrease in the number of enterochromaffin cells. In the small intestine pentagastrin 0.6 micrograms/kg increased the serotonin level and decreased that of 5-HIAA, in a dose of 3 micrograms/kg it decreased only the 5-HIAA level, and in the 6 micrograms/kg dose it had no effect on the levels of these substances. Oxyphenonium increased only the intestinal 5-HIAA level but only when administered in a dose of 5 mg/kg. In the brain both higher doses of pentagastrin decreased the serotonin level, and all three doses raised significantly the 5-HIAA level. Oxyphenonium in the higher dose raised the brain serotonin level, but was without effect on the 5-HIAA level. The blood serotonin level was not changed by pentagastrin and oxyphenonium.

Animals↗

Effects of octopamine on GABA-ergic transmission in rats.

The behavioral effects of octopamine (50, 100 and 250 micrograms/rat ivc) and GABA-ergic drugs alone or in combination were studied in rats. Octopamine significantly increased locomotor activity in all doses tested. In rats pretreated with muscimol (0.5 mg/kg sc) or baclofen (2.5 mg/kg ip) octopamine did not produce hyperactivity. Octopamine in all doses did not affect bicuculline (3.5 mg/kg sc) -induced convulsions. Picrotoxin (0.4 mg/kg sc) inhibited the stimulatory action of octopamine but at the same time produced signs of toxicity. Biochemical studies showed that octopamine decreased the cerebral concentration of GABA and reduced activity of GAD in rats brain. Significant changes in concentrations of NA and DA in brain of rats pretreated with baclofen and octopamine were found.

Animals↗